Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05671887 · ClinicalTrials.gov registry record

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

A clinical trial of Lung Cancer and Lung Transplant, sponsored by Northwestern University.

Recruiting
Registry status
125
Enrollment target
1
Study location

NCT05671887 is a study of Lung Cancer and Lung Transplant that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 125 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05671887, a study of Lung Cancer and Lung Transplant, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
125 participants
Enrollment target
1
Study location

Study Summary

This is a prospective observational registration trial for patients who undergo lung transplantation for the treatment of the select groups of medically refractory cancers affecting the lungs alone without extrapulmonary nodal and distant metastasis.

Interventions

  • PROCEDURE Double Lung Transplantation

Study Locations (1)

Illinois

  • Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital) - Chicago

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2022-11-16
Est. Completion 2032-11

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT05671887

The ClinicalTrials.gov registry entry for NCT05671887 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Double Lung Transplantation is the first listed.

NCT05671887 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05671887 about?

NCT05671887 is a clinical study titled "DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies". This is a prospective observational registration trial for patients who undergo lung transplantation for the treatment of the select groups of medically refractory cancers affecting the lungs alone without extrapulmonary nodal and distant metastasis.

What is the current status of trial NCT05671887?

This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2022-11-16. Estimated completion is 2032-11.

What conditions does trial NCT05671887 study?

This clinical trial studies the following conditions: Lung Cancer, Lung Transplant, Bilateral Cancer.

What interventions are being tested in trial NCT05671887?

The interventions under investigation include: Double Lung Transplantation (PROCEDURE).

Who is sponsoring clinical trial NCT05671887?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05671887 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.